FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)
CUSIP: 31447P100
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common stock, no par value (the "Shares")
- Shares outstanding
- 34,145,841
- Total 13F shares
- 8,988,085
- Share change
- -617,661
- Total reported value
- $35,952,664
- Price per share
- $4.00
- Number of holders
- 25
- Value change
- -$3,100,726
- Number of buys
- 8
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
3,997,214
|
$19,386,000 | — | 31 Mar 2019 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.2%
|
1,105,999
|
$5,364,000 | — | 31 Mar 2019 | |
| 683 Capital Management, LLC |
13F
|
Company |
2.8%
|
971,351
|
$4,711,000 | — | 31 Mar 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
720,000
|
$3,492,000 | — | 31 Mar 2019 | |
| Opaleye Management Inc. |
13F
|
Company |
1.8%
|
630,000
|
$3,056,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.6%
|
539,779
|
$2,618,000 | — | 31 Mar 2019 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.2%
|
410,932
|
$1,993,000 | — | 31 Mar 2019 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.77%
|
262,033
|
$1,271,000 | — | 31 Mar 2019 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.51%
|
174,050
|
$844,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.49%
|
167,372
|
$812,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
102,077
|
$495,000 | — | 31 Mar 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.25%
|
84,750
|
$411,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
46,059
|
$223,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.14%
|
46,134
|
$222,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.13%
|
45,067
|
$219,000 | — | 31 Mar 2019 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.12%
|
42,165
|
$205,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
31,100
|
$151,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
27,211
|
$132,000 | — | 31 Mar 2019 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.07%
|
25,000
|
$121,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
22,789
|
$111,000 | — | 31 Mar 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
18,673
|
$91,000 | — | 31 Mar 2019 | |
| Zebra Capital Management LLC |
13F
|
Company |
0.05%
|
17,568
|
$85,000 | — | 31 Mar 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.05%
|
15,600
|
$76,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
15,408
|
$75,000 | — | 31 Mar 2019 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.04%
|
15,254
|
$74,000 | — | 31 Mar 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
13,375
|
$65,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
12,626
|
$61,000 | — | 31 Mar 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
12,400
|
$60,000 | — | 31 Mar 2019 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.04%
|
12,300
|
$60,000 | — | 31 Mar 2019 | |
| Wealthspire Advisors, L.P. |
13F
|
Company |
0.03%
|
9,500
|
$46,000 | — | 31 Mar 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
9,304
|
$44,000 | — | 31 Mar 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.02%
|
7,710
|
$37,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,535
|
$17,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,512
|
$17,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
3,416
|
$17,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
3,313
|
$16,000 | — | 31 Mar 2019 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
3,300
|
$16,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
2,831
|
$14,000 | — | 31 Mar 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
2,660
|
$12,901 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
2,323
|
$11,000 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,681
|
$8,000 | — | 31 Mar 2019 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
914
|
$4,000 | — | 31 Mar 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
315
|
$2,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
311
|
$2,000 | — | 31 Mar 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
203
|
$1,000 | — | 31 Mar 2019 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1
|
$5 | — | 31 Mar 2019 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q2 2019
As of 30 Jun 2019,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,988,085 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, 683 Capital Management, LLC, Solas Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Opaleye Management Inc., UNITED SERVICES AUTOMOBILE ASSOCIATION, NORTHERN TRUST CORP, and OxFORD Asset Management LLP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
44
Q2 2019 holders
25
Holder diff
-19
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.